Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
If you compete in sport, check your league rules
Tirzepatide (GLP-1/GIP) Tirzepatide is a first-in-class dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist, providing synergistic metabolic effects for diabetes and obesity research
Clinical research has suggested that the levels of FOXO proteins in the central nervous system may be altered in research models of neurodegenerative disorders (NDDs)
Matching dosage protocols Related protocols and comparisons Further research context REFERENCES National Center for Biotechnology Information
US$ 29.76
US$ 25.17
US$ 28.57
